GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (FRA:ABL) » Definitions » Cyclically Adjusted Price-to-FCF

Abbott Laboratories (FRA:ABL) Cyclically Adjusted Price-to-FCF : 31.36 (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), Abbott Laboratories's current share price is €94.71. Abbott Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €3.02. Abbott Laboratories's Cyclically Adjusted Price-to-FCF for today is 31.36.

The historical rank and industry rank for Abbott Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:ABL' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 9.31   Med: 21.75   Max: 48.66
Current: 31.53

During the past years, Abbott Laboratories's highest Cyclically Adjusted Price-to-FCF was 48.66. The lowest was 9.31. And the median was 21.75.

FRA:ABL's Cyclically Adjusted Price-to-FCF is ranked better than
58.9% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 44.395 vs FRA:ABL: 31.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abbott Laboratories's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €0.330. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €3.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted Price-to-FCF Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.24 38.46 47.68 36.85 34.54

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.11 35.22 30.48 34.54 34.72

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Abbott Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Abbott Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=94.71/3.02
=31.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Abbott Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.33/131.7762*131.7762
=0.330

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.311 100.560 0.408
201409 0.472 100.428 0.619
201412 0.507 99.070 0.674
201503 -0.142 99.621 -0.188
201506 0.429 100.684 0.561
201509 0.464 100.392 0.609
201512 0.356 99.792 0.470
201603 -0.203 100.470 -0.266
201606 0.398 101.688 0.516
201609 0.546 101.861 0.706
201612 0.544 101.863 0.704
201703 0.163 102.862 0.209
201706 0.558 103.349 0.711
201709 0.833 104.136 1.054
201712 0.623 104.011 0.789
201803 0.383 105.290 0.479
201806 0.458 106.317 0.568
201809 0.885 106.507 1.095
201812 0.643 105.998 0.799
201903 0.188 107.251 0.231
201906 0.294 108.070 0.358
201909 0.787 108.329 0.957
201912 1.001 108.420 1.217
202003 0.180 108.902 0.218
202006 0.338 108.767 0.410
202009 0.746 109.815 0.895
202012 1.432 109.897 1.717
202103 1.050 111.754 1.238
202106 0.794 114.631 0.913
202109 1.064 115.734 1.211
202112 1.218 117.630 1.364
202203 0.892 121.301 0.969
202206 1.088 125.017 1.147
202209 1.325 125.227 1.394
202212 0.924 125.222 0.972
202303 0.407 127.348 0.421
202306 0.367 128.729 0.376
202309 0.706 129.860 0.716
202312 1.199 129.419 1.221
202403 0.330 131.776 0.330

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott Laboratories  (FRA:ABL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Abbott Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (FRA:ABL) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.